Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust

Vaccine panel's hepatitis B vote signals further turbulence for immunization policy, public trust

Clinicians and epidemiologists warn the decision could unravel decades of progress and expose newborns to a deadly, preventable disease.

Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust

When Su Wang was in medical school, she donated blood. That’s when she learned she was infected with hepatitis B, a virus that attacks the liver and can lead to cancer and death decades later. “I was 18, healthy, in college,” she said. “And suddenly I had a chronic illness I didn’t even know about.” Born in Florida in 1975, Wang grew up before the hepatitis B vaccine was routinely given to newborns. For years, she assumed she had been infected b…

Global Health Watch: 4 African Countries Sign Bilateral Health MoUs with US, New People’s Research Agenda, Hepatitis B Vaccine Shift

This week covers fast-moving developments with new US bilateral Memos of Understanding (MoU) across Africa, including reactions from Kenya’s High Court, which suspended the agreement over the issue of sharing of health data, alongside new reporting on the adverse impact of US policy changes affecting science and research institutions, and a major reversal in US hepatitis B vaccine policy. We also track the newly updated People’s Research Agenda.…

ACIP’s Reversal on Hepatitis B Birth Dose Raises Alarms Over Preventable Infections

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.